HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroshi Fuji Selected Research

Hiroshi Fuji Research Topics

Disease

18Neoplasms (Cancer)
02/2024 - 10/2005
3Prostatic Neoplasms (Prostate Cancer)
10/2011 - 06/2005
2Brain Neoplasms (Brain Tumor)
02/2024 - 06/2019
2Neuroblastoma
08/2020 - 11/2013
2Hepatoblastoma
01/2020 - 12/2017
2Neoplasm Metastasis (Metastasis)
12/2017 - 02/2015
2Lymphoma (Lymphomas)
09/2009 - 09/2002
1Necrosis
02/2024
1Central Nervous System Neoplasms
02/2024
1Germinoma
01/2022
1Second Primary Neoplasms (Neoplasms, Second)
07/2021
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2021
1Interstitial Nephritis (Tubulointerstitial Nephritis)
01/2021
1Leukemia
01/2020
1Hepatocellular Carcinoma (Hepatoma)
11/2019
1Chronic Granulomatous Disease
01/2019
1Rhabdomyosarcoma
01/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2016
1Poliomyelitis (Polio)
12/2014
1Paraparesis
12/2014
1Melanoma (Melanoma, Malignant)
07/2014
1Medulloblastoma
03/2014
1Hearing Loss (Hearing Impairment)
03/2014
1Respiratory Insufficiency (Respiratory Failure)
09/2012
1Chordoma
05/2011
1Chondrosarcoma
05/2011
1Radiation Pneumonitis
05/2010
1Esophageal Neoplasms (Esophageal Cancer)
05/2010
1B-Cell Lymphoma (Lymphoma, B Cell)
09/2009
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
12/2008
1Lower Urinary Tract Symptoms
12/2008
1Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2003

Drug/Important Bio-Agent (IBA)

6Protons (Proton)IBA
01/2018 - 10/2005
2Cisplatin (Platino)FDA LinkGeneric
01/2020 - 05/2010
1TinIBA
01/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020
1pirarubicinIBA
01/2020
1Busulfan (Busulfex)FDA Link
01/2019
1Voriconazole (Vfend)FDA LinkGeneric
09/2012
1Micafungin (FK463)FDA Link
09/2012
1Anti-Bacterial Agents (Antibiotics)IBA
09/2012
1Itraconazole (Sporanox)FDA LinkGeneric
09/2012
1Fluorouracil (Carac)FDA LinkGeneric
05/2010
1AntigensIBA
09/2009
1silodosinFDA Link
12/2008
1Docetaxel (Taxotere)FDA Link
11/2006
1DNA (Deoxyribonucleic Acid)IBA
09/2002
1Alkylating AgentsIBA
09/2002
1MHC class II transactivator proteinIBA
09/2002

Therapy/Procedure

16Radiotherapy
02/2024 - 06/2005
15Proton Therapy
07/2021 - 10/2005
7Drug Therapy (Chemotherapy)
01/2022 - 03/2003
2Induction Chemotherapy
08/2020 - 12/2017
2Chemoradiotherapy
02/2015 - 05/2010
2Drug Tapering
03/2014 - 11/2013
2Brachytherapy
06/2005 - 03/2003
1Re-Irradiation
02/2024
1Nephroureterectomy
01/2021
1Combined Modality Therapy
08/2020
1Hepatectomy
11/2019
1Homologous Transplantation
01/2019
1Metastasectomy
12/2017
1Argon Plasma Coagulation
02/2015
1Lymph Node Excision (Lymph Node Dissection)
12/2014
1Proctectomy
12/2014
1Aftercare (After-Treatment)
03/2014
1Therapeutics
09/2012
1Synchrotrons
11/2009